Abbott Laboratories has restarted production of its Similac infant formula at the plant in Sturgis, Michigan at the center of the U.S. baby formula shortage.
Abbott Laboratories said on Wednesday it was set to recapture some of the market share in the baby formula business as the company restarts manufacturing at its troubled Michigan facility in the United States.
Abbott Laboratories said on Saturday that the company has reopened its baby formula production plant in Sturgis, Michigan, taking a step toward alleviating an acute nationwide shortage that has sent parents scrambling for supplies.
U.S. President Joe Biden will meet with major infant formula manufacturers on Wednesday as his administration presses ahead with efforts to boost imported supplies to help ease a nationwide shortage.
Lawmakers grilled U.S. Food and Drug Administration officials on Wednesday over what they saw as a lack of urgency in the agency’s response to complaints about possible baby formula contamination at a now shuttered Abbott Laboratories plant that led to severe nationwide shortages.
The Federal Trade Commission said on Tuesday it has launched an inquiry into the ongoing shortage for infant formula.